Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL7AP5 (ribosomal protein L7a pseudogene 5) is a processed pseudogene in humans and does not encode a functional protein[7][5]. Pseudogenes are non-functional segments of DNA that arise from gene duplication or retrotransposition and typically lack the ability to produce active gene products. RPL7AP5 shares sequence similarity with the functional ribosomal protein L7a gene (RPL7A), which codes for a protein component of the 60S ribosomal subunit involved in protein synthesis[1][4]. However, RPL7AP5 itself is not transcribed or translated into a functional protein and does not participate directly in any known biological pathways or disease processes. It is not classified as a receptor, enzyme, transporter, or any other type of drug target, and there are no drugs, biomarkers, or safety considerations relevant to this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 5 (RPL7AP5).